Wilmington, DE, Oct. 08, 2025 (GLOBE NEWSWIRE) -- Enovis™ Corporation (“Enovis” or “the Company”) (NYSE: ENOV), an innovation-driven medical technology…
New platform module automates previous manual vaccine design processes, improving quality and dramatically reducing time and resource requirementsAI-Immunology™, already superior…
ROCKVILLE, Md., Oct. 08, 2025 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (NASDAQ: MXCT), a leading, cell-engineering focused company providing enabling platform…
Launch Follows IM8’s Record Growth to $6.6 Million Monthly Revenue in September IM8 Accelerates Toward $100 Million ARR Milestone with…
Strategic collaboration with leading global manufacturer of drug delivery systems strengthens NS002's clinical and commercial roadmap with end-to-end development support…
PARAMUS, N.J., Oct. 08, 2025 (GLOBE NEWSWIRE) -- Starton Therapeutics Inc. (“Starton”), a clinical-stage biotechnology company transforming standard-of-care therapies with…
New 5-Pillar Framework Promises to Transform Scattered Compliance Records Into Audit-Ready Systems NEW YORK, Oct. 8, 2025 /PRNewswire/ -- Compliancy Group,…
The DEA Regulatory Revolving Door Spins AgainAfter years of blocking FDA approved cannabis research for Huntington's and Multiple Sclerosis, former…
PALO ALTO, CALIFORNIA / ACCESS Newswire / October 8, 2025 / Bioz, Inc, a pioneer in AI-driven citation management, is…
Appointment of Executive Chairman, proposed change of name and strategy updateCompany to pursue revised strategy and name change to CelLBxHealth…